title: Comparative evaluation of whole body and hepatic insulin resistance using indices from oral glucose tolerance test in morbidly obese subjects with nonalcoholic Fatty liver disease.
abstract: Nonalcoholic Fatty Liver Disease (NAFLD) is the hepatic manifestation of metabolic syndrome and is a marker of Insulin Resistance (IR). Euglycemic-hyperinsulinemic clamp is the gold standard for measuring whole body IR (hepatic + peripheral IR). However, it is an invasive and expensive procedure. Homeostasis Model Assessment Index for Insulin Sensitivity (HOMA-IS), Quantitative Insulin Sensitivity Check Index (QUICKI) for hepatic IR and Insulin Sensitivity Index (ISI(0,120)), and Whole Body Insulin Sensitivity Index (WBISI) for whole body IR are the indices calculated after Oral Glucose Tolerance Test (OGTT). We used these indices as noninvasive methods of IR (inverse of insulin sensitivity) estimation and compared hepatic/peripheral components of whole body IR in NAFLD. Methods. 113 morbidly obese, nondiabetic subjects who underwent gastric bypass surgery and intraoperative liver biopsy were included in the study. OGTT was performed preoperatively and the indices were calculated. Subjects were divided into closely matched groups as normal, fatty liver (FL) and Non-Alcoholic Steatohepatitis (NASH) based on histology. Results. Whole body IR was significantly higher in both FL and NASH groups (NAFLD) as compared to Normal, while hepatic IR was higher only in NASH from Normal. Conclusions. FL is a manifestation of peripheral IR but not hepatic IR.
authors.affiliation: Department of Medicine, University of Illinois at Urbana, Champaign, IL 61801, USA.
authors.forename: Kamran
authors.initials: K
authors.lastname: Qureshi
authors.forename: Ronald H
authors.initials: RH
authors.lastname: Clements
authors.forename: Fahad
authors.initials: F
authors.lastname: Saeed
authors.forename: Gary A
authors.initials: GA
authors.lastname: Abrams
references.citation: J Clin Endocrinol Metab. 2003 Jun;88(6):2399-403
references.pmid: 12788834
references.citation: Hepatology. 2002 Feb;35(2):373-9
references.pmid: 11826411
references.citation: J Hepatol. 1998 Sep;29(3):495-501
references.pmid: 9765002
references.citation: Clin Chem Lab Med. 2006;44(7):817-23
references.pmid: 16776626
references.citation: Am J Gastroenterol. 2007 Feb;102(2):399-408
references.pmid: 17311652
references.citation: Scand J Clin Lab Invest. 1985 Dec;45(8):741-51
references.pmid: 3909372
references.citation: Diabetologia. 1996 Mar;39(3):298-305
references.pmid: 8721775
references.citation: Am J Gastroenterol. 1999 Sep;94(9):2467-74
references.pmid: 10484010
references.citation: Diabetologia. 1985 Jul;28(7):412-9
references.pmid: 3899825
references.citation: World J Gastroenterol. 2007 Jul 14;13(26):3540-53
references.pmid: 17659704
references.citation: Hypertens Res. 2002 Jul;25(4):529-36
references.pmid: 12358137
references.citation: Gut. 2005 Jul;54(7):1003-8
references.pmid: 15951550
references.citation: Hepatology. 2005 Jun;41(6):1313-21
references.pmid: 15915461
references.citation: Nutr Metab Cardiovasc Dis. 2004 Dec;14(6):366-72
references.pmid: 15853121
references.citation: Gut. 2007 Sep;56(9):1296-301
references.pmid: 17392334
references.citation: Diabetes. 1999 Sep;48(9):1801-6
references.pmid: 10480611
references.citation: Am J Physiol. 1979 Sep;237(3):E214-23
references.pmid: 382871
references.citation: Diabetologia. 1995 Jun;38(6):699-704
references.pmid: 7672492
references.citation: N Engl J Med. 1987 Aug 6;317(6):350-7
references.pmid: 3299096
references.citation: Diabetes Res Clin Pract. 2000 Mar;47(3):177-84
references.pmid: 10741566
references.citation: Hepatology. 2002 Dec;36(6):1349-54
references.pmid: 12447858
references.citation: Hepatology. 2003 Apr;37(4):917-23
references.pmid: 12668987
references.citation: Gastroenterology. 2005 Jun;128(7):1898-906
references.pmid: 15940625
references.citation: J Clin Endocrinol Metab. 1988 Mar;66(3):580-3
references.pmid: 3350907
references.citation: Am J Physiol Endocrinol Metab. 2006 Oct;291(4):E697-703
references.pmid: 16684857
references.citation: J Clin Endocrinol Metab. 2000 Jul;85(7):2402-10
references.pmid: 10902785